Commentary - (2025) Volume 16, Issue 6
Received: 01-Dec-2025, Manuscript No. jtse-26-184789;
Editor assigned: 03-Dec-2025, Pre QC No. P-184789;
Reviewed: 17-Dec-2025, QC No. Q-184789;
Revised: 22-Dec-2025, Manuscript No. R-184789;
Published:
29-Dec-2025
, DOI: 10.37421/2157-7552.2025.16.467
Citation: Kulkarni, Nandini. ”Advancing Musculoskeletal Regeneration: Biomaterials, Cells, and Therapies.” J Tissue Sci Eng 16 (2025):467.
Copyright: © 2025 Kulkarni N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The field of tissue engineering has witnessed significant advancements, offering novel strategies for the regeneration of damaged or diseased tissues. A primary focus has been on musculoskeletal tissues, which are prone to injury and degeneration due to their mechanical load-bearing functions. Recent research has explored a multidisciplinary approach, integrating biomaterials, cellular therapies, and advanced engineering techniques to address these challenges. The development of sophisticated biomaterials that mimic the native extracellular matrix (ECM) is crucial for providing a supportive environment for cell growth and differentiation. These scaffolds serve as a template for new tissue formation, guiding cellular behavior and promoting functional restoration. The precise design of these materials can influence cell adhesion, proliferation, and the ultimate structure of the regenerated tissue [1].
Cellular therapies, particularly those involving stem cells, have emerged as a cornerstone of regenerative medicine. Mesenchymal stem cells (MSCs) are highly attractive due to their multipotent differentiation capacity and immunomodulatory properties. Their ability to differentiate into various cell types relevant to musculoskeletal tissues, such as chondrocytes, osteoblasts, and myoblasts, makes them a promising therapeutic tool [1].
In the realm of cartilage repair, specific molecular mechanisms are being investigated to enhance chondrogenesis, the process by which cartilage is formed. MicroRNAs (miRNAs), small non-coding RNA molecules, play a critical role in regulating gene expression and have been identified as key players in stem cell differentiation and inflammatory responses within the joint. Understanding these miRNA-mediated pathways offers new avenues for targeted therapeutic interventions aimed at improving cartilage regeneration outcomes [2].
Bone tissue engineering has seen considerable progress with the advent of additive manufacturing technologies. 3D bioprinting, in particular, allows for the fabrication of complex, patient-specific bone grafts. This technology enables the precise placement of cells and biomaterials, creating constructs with intricate architectures that can promote vascularization and integration with host bone tissue, thereby addressing critical bone defects [3].
For skeletal muscle regeneration, the use of decellularized extracellular matrix (dECM) has gained traction. dECM retains the structural and biochemical cues of the native tissue, providing an excellent natural scaffold. Its composition and biomechanical properties are vital for supporting myoblast behavior, including proliferation, differentiation, and fusion, which are essential steps in muscle repair [4].
Mesenchymal stem cells (MSCs) are not only important for their differentiation potential but also for their potent immunomodulatory capabilities. In the context of joint repair, MSCs can modulate the immune response, suppressing inflammation and creating a more conducive environment for tissue regeneration. This property is particularly relevant for treating inflammatory joint diseases and enhancing the overall success of regenerative therapies [9].
Extracellular vesicles (EVs) derived from MSCs represent a cell-free therapeutic approach with significant potential. These vesicles carry bioactive molecules that can influence cellular processes, such as inflammation and matrix metabolism. For osteoarthritis treatment, MSC-derived EVs have shown promise in modulating inflammatory pathways, supporting chondrocyte survival, and inhibiting matrix degradation, offering a novel alternative to cell-based therapies [5].
Smart hydrogels are being developed to provide a dynamic and responsive platform for delivering therapeutic agents in tissue regeneration. These materials can release growth factors or anti-inflammatory drugs in a controlled manner, triggered by specific physiological cues like pH or temperature. This targeted delivery optimizes the regenerative process and minimizes potential side effects, aligning with the principles of personalized regenerative medicine [8].
To effectively evaluate the success of these regenerative strategies, advanced imaging techniques are indispensable. Modalities such as micro-computed tomography (micro-CT) and magnetic resonance imaging (MRI) allow for non-invasive assessment of the quality and extent of regenerated tissues. These techniques provide detailed information on bone mineralization, cartilage integrity, and muscle structure, aiding in treatment monitoring and the development of more effective therapies [10].
The advancement of biomaterials and cellular therapies is fundamentally reshaping the landscape of musculoskeletal tissue regeneration. A key development involves the creation of scaffolds that closely mimic the native extracellular matrix (ECM), providing a conducive environment for cellular activities essential for tissue repair. These biomaterials are engineered to support cell adhesion, proliferation, and differentiation, guiding the formation of new tissue structures with desired mechanical and functional properties [1].
Stem cells, particularly mesenchymal stem cells (MSCs), are central to many regenerative strategies. Their capacity for differentiation into various cell lineages relevant to musculoskeletal tissues, coupled with their potent immunomodulatory effects, makes them highly versatile therapeutic agents. Research is continually exploring ways to optimize their use, including enhancing their survival, engraftment, and functional integration within the target tissue [1].
In the context of cartilage repair, a deeper understanding of the molecular regulators of chondrogenesis is crucial. MicroRNAs (miRNAs) have emerged as critical players in controlling stem cell differentiation into chondrocytes and modulating the inflammatory milieu within joints. Identifying and manipulating specific miRNAs holds promise for developing targeted therapies that can effectively enhance cartilage regeneration [2].
For bone regeneration, 3D bioprinting technology offers unprecedented control over scaffold architecture and cell distribution. This advanced manufacturing technique allows for the creation of complex bone grafts that can mimic native bone structure and facilitate vascularization, which is essential for the survival and integration of larger bone constructs. The ability to engineer these intricate structures addresses limitations of traditional bone grafts and bone defect treatments [3].
Skeletal muscle regeneration is significantly aided by the use of decellularized extracellular matrix (dECM) as a biomaterial scaffold. The dECM preserves the inherent biological cues and structural integrity of the native muscle tissue. This natural scaffolding material supports myoblast proliferation, differentiation, and the fusion processes necessary for effective muscle repair, highlighting the importance of biomimicry in regenerative approaches [4].
The immunomodulatory functions of mesenchymal stem cells (MSCs) are increasingly recognized as vital for successful joint regeneration. By suppressing pro-inflammatory responses and fostering an anti-inflammatory microenvironment, MSCs can create conditions that are highly favorable for tissue repair and regeneration. This capability is particularly beneficial for managing inflammatory joint diseases [9].
Extracellular vesicles (EVs) released by MSCs are gaining attention as a cell-free therapeutic option for osteoarthritis. These vesicles deliver bioactive molecules that can exert anti-inflammatory effects, promote chondrocyte survival, and inhibit the degradation of the cartilage matrix. This approach offers a potentially safer and more controlled therapeutic strategy compared to direct cell transplantation [5].
To enhance the creation of porous scaffolds for bone tissue engineering, synergistic approaches like combining electrospinning and particulate leaching are being employed. These methods allow for the precise control of scaffold porosity and interconnectivity, which are critical factors influencing osteoblast behavior and bone formation. Hybrid scaffolds developed through such techniques often demonstrate improved osteogenic potential [6].
The development of smart hydrogels represents a significant step forward in controlled drug delivery for tissue regeneration. These responsive materials can release therapeutic agents, such as growth factors, in a regulated manner based on the local physiological environment. This targeted and on-demand delivery system optimizes therapeutic efficacy and minimizes systemic side effects, enhancing the precision of regenerative treatments [8].
Accurate assessment of regenerated tissue is paramount for evaluating therapeutic success. Advanced imaging modalities, including micro-CT and MRI, provide non-invasive means to monitor tissue development and quality. These techniques enable detailed analysis of bone mineralization, cartilage integrity, and muscle structure, offering crucial insights for treatment optimization and future therapeutic design [10].
This compilation of research highlights advancements in musculoskeletal tissue regeneration, focusing on cartilage, bone, and muscle repair. Key areas of exploration include the use of biomaterials like extracellular matrix scaffolds and smart hydrogels, alongside cellular therapies such as mesenchymal stem cells (MSCs) and their derived extracellular vesicles (EVs). Techniques like 3D bioprinting and gene therapy are being investigated for bone and muscle regeneration, respectively. The role of microRNAs in chondrogenesis and the immunomodulatory properties of MSCs are crucial for understanding and improving joint repair. Advanced imaging techniques are essential for evaluating the efficacy of these regenerative strategies. Promising therapeutic approaches are emerging for conditions like osteoarthritis and muscular dystrophy.
None
None
Journal of Tissue Science and Engineering received 807 citations as per Google Scholar report
